Procollagen-proline dioxygenase explained

Procollagen-proline dioxygenase
Ec Number:1.14.11.2
Cas Number:9028-06-2
Go Code:0004656

Procollagen-proline dioxygenase, commonly known as prolyl hydroxylase, is a member of the class of enzymes known as alpha-ketoglutarate-dependent hydroxylases. These enzymes catalyze the incorporation of oxygen into organic substrates through a mechanism that requires alpha-Ketoglutaric acid, Fe2+, and ascorbate.[1] [2] This particular enzyme catalyzes the formation of (2S, 4R)-4-hydroxyproline, a compound that represents the most prevalent post-translational modification in the human proteome.[3]

Enzyme mechanism

Procollagen-proline dioxygenase catalyzes the following reaction:

L-proline + alpha-ketoglutaric acid + O2 → (2S, 4R)-4-hydroxyproline + succinate + CO2

The mechanism for the reaction is similar to that of other dioxygenases, and occurs in two distinct stages:[3] In the first, a highly reactive Fe(IV)=O species is produced. Molecular oxygen is bound end-on in an axial position, producing a dioxygen unit. Nucleophilic attack on C2 generates a tetrahedral intermediate, with loss of the double bond in the dioxygen unit and bonds to iron and the alpha carbon of 2-oxoglutarate. Subsequent elimination of CO2 coincides with the formation of the Fe(IV)=O species. The second stage involves the abstraction of the pro-R hydrogen atom from C-4 of the proline substrate followed by radical combination, which yields hydroxyproline.[4]

As a consequence of the reaction mechanism, one molecule of 2-oxoglutarate is decarboxylated, forming succinate. This succinate is hydrolyzed and replaced with another 2-oxoglutarate after each reaction, and it has been concluded that in the presence of 2-oxoglutarate, enzyme-bound Fe2+ is rapidly converted to Fe3+, leading to inactivation of the enzyme.[5] Ascorbate is utilized as a cofactor to reduce Fe3+ back to Fe2+.[6]

Enzyme structure

Prolyl hydroxylase is a tetramer with 2 unique subunits.[7] The α subunit is 59 kDa and is responsible for both peptide binding and for catalytic activity.[8] The peptide binding domain spans residues 140-215 of the α subunit,[9] and consists of a concave surface lined with multiple tyrosine residues which interact favorably with the proline-rich substrate. The active site consists of Fe2+ bound to two histidine residues and one aspartate residue, a characteristic shared by most 2-oxoglutarate-dependent dioxygenases. The 55 kDa β subunit is responsible for the enzyme’s localization to and retention in the endoplasmic reticulum.[10] This subunit is identical to the enzyme known as protein disulfide isomerase.[11]

Biological function

Prolyl hydroxylase catalyzes the formation of hydroxyproline. The modification has a significant impact on the stability of collagen, the major connective tissue of the human body.[12] Specifically, hydroxylation increases the melting temperature (Tm) of helical collagen by 16 °C, as compared to unhydroxylated collagen,[13] a difference that allows the protein to be stable at body temperature. Due to the abundance of collagen (about one third of total protein) in humans, and the high occurrence of this modification in collagen, hydroxyproline is quantitatively the most abundant post-translational modification in humans.[14]

The enzyme acts specifically on proline contained within the X-Pro-Gly motif – where Pro is proline. Because of this motif-specific behavior, the enzyme also acts on other proteins that contain this same sequence. Such proteins include C1q,[15] elastins,[16] PrP,[17] Argonaute 2,[18] and conotoxins,[19] among others.

Disease relevance

As prolyl hydroxylase requires ascorbate as a cofactor to function,[5] its absence compromises the enzyme’s activity. The resulting decreased hydroxylation leads to the disease condition known as scurvy. Since stability of collagen is compromised in scurvy patients, symptoms include weakening of blood vessels causing purpura, petechiae, and gingival bleeding.

Hypoxia-inducible factor (HIF) is an evolutionarily conserved transcription factor[20] that allows the cell to respond physiologically to decreases in oxygen.[21] A class of prolyl hydroxylases which act specifically on HIF has been identified;[22] hydroxylation of HIF allows the protein to be targeted for degradation.[22] HIF prolyl-hydroxylase has been targeted by a variety of inhibitors that aim to treat stroke,[23] kidney disease,[24] ischemia,[25] anemia,[26] and other important diseases.

Alternate names

External links

Notes and References

  1. Smith TG, Talbot NP . Prolyl hydroxylases and therapeutics . Antioxidants & Redox Signaling . 12 . 4 . 431–3 . April 2010 . 19761407 . 10.1089/ars.2009.2901 .
  2. Hutton JJ, Trappel AL, Udenfriend S . Requirements for alpha-ketoglutarate, ferrous ion and ascorbate by collagen proline hydroxylase . Biochemical and Biophysical Research Communications . 24 . 2 . 179–84 . July 1966 . 5965224 . 10.1016/0006-291x(66)90716-9 .
  3. Gorres KL, Raines RT . Prolyl 4-hydroxylase . Critical Reviews in Biochemistry and Molecular Biology . 45 . 2 . 106–24 . April 2010 . 20199358 . 2841224 . 10.3109/10409231003627991 .
  4. 10.1021/ja01075a036. The Preparation of cis- and trans-4-H3-L-Prolines and Their Use in Studying the Mechanism of Enzymatic Hydroxylation in Chick Embryos. Journal of the American Chemical Society. 86. 21. 4709–4716. 1964. Fujita Y, Gottlieb A, Peterkofsky B, Udenfriend S, Witkop B .
  5. de Jong L, Albracht SP, Kemp A . Prolyl 4-hydroxylase activity in relation to the oxidation state of enzyme-bound iron. The role of ascorbate in peptidyl proline hydroxylation . Biochimica et Biophysica Acta . 704 . 2 . 326–32 . June 1982 . 6285984 . 10.1016/0167-4838(82)90162-5 .
  6. De Jong L, Kemp A . Stoicheiometry and kinetics of the prolyl 4-hydroxylase partial reaction . Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology . 787 . 1 . 105–11 . May 1984 . 6326839 . 10.1016/0167-4838(84)90113-4 .
  7. Berg RA, Prockop DJ . Affinity column purification of protocollagen proline hydroxylase from chick embryos and further characterization of the enzyme . The Journal of Biological Chemistry . 248 . 4 . 1175–82 . February 1973 . 10.1016/S0021-9258(19)44278-6 . 4346946 . free .
  8. Helaakoski T, Vuori K, Myllylä R, Kivirikko KI, Pihlajaniemi T . Molecular cloning of the alpha-subunit of human prolyl 4-hydroxylase: the complete cDNA-derived amino acid sequence and evidence for alternative splicing of RNA transcripts . Proceedings of the National Academy of Sciences of the United States of America . 86 . 12 . 4392–6 . June 1989 . 2543975 . 287275 . 10.1073/pnas.86.12.4392 . 1989PNAS...86.4392H . free .
  9. Pekkala M, Hieta R, Bergmann U, Kivirikko KI, Wierenga RK, Myllyharju J . The peptide-substrate-binding domain of collagen prolyl 4-hydroxylases is a tetratricopeptide repeat domain with functional aromatic residues . The Journal of Biological Chemistry . 279 . 50 . 52255–61 . December 2004 . 15456751 . 10.1074/jbc.M410007200 . free .
  10. Vuori K, Pihlajaniemi T, Myllylä R, Kivirikko KI . Site-directed mutagenesis of human protein disulphide isomerase: effect on the assembly, activity and endoplasmic reticulum retention of human prolyl 4-hydroxylase in Spodoptera frugiperda insect cells . The EMBO Journal . 11 . 11 . 4213–7 . November 1992 . 10.1002/j.1460-2075.1992.tb05515.x . 1327760 . 556932 .
  11. Pihlajaniemi T, Helaakoski T, Tasanen K, Myllylä R, Huhtala ML, Koivu J, Kivirikko KI . Molecular cloning of the beta-subunit of human prolyl 4-hydroxylase. This subunit and protein disulphide isomerase are products of the same gene . The EMBO Journal . 6 . 3 . 643–9 . March 1987 . 10.1002/j.1460-2075.1987.tb04803.x . 3034602 . 553446 .
  12. Shoulders MD, Raines RT . Collagen structure and stability . Annual Review of Biochemistry . 78 . 929–58 . 2009 . 19344236 . 2846778 . 10.1146/annurev.biochem.77.032207.120833 .
  13. Berg RA, Prockop DJ . The thermal transition of a non-hydroxylated form of collagen. Evidence for a role for hydroxyproline in stabilizing the triple-helix of collagen . Biochemical and Biophysical Research Communications . 52 . 1 . 115–20 . May 1973 . 4712181 . 10.1016/0006-291x(73)90961-3 .
  14. Gorres . Kelly L. . Raines . Ronald T. . Prolyl 4-hydroxylase . Critical Reviews in Biochemistry and Molecular Biology . April 2010 . 45 . 2 . 106–124 . 10.3109/10409231003627991. 20199358 . 2841224 .
  15. Müller W, Hanauske-Abel H, Loos M . Biosynthesis of the first component of complement by human and guinea pig peritoneal macrophages: evidence for an independent production of the C1 subunits . Journal of Immunology . 121 . 4 . 1578–84 . October 1978 . 10.4049/jimmunol.121.4.1578 . 701808 . 36397927 . free .
  16. Rosenbloom J, Cywinski A . Inhibition of proline hydroxylation does not inhibit secretion of tropoelastin by chick aorta cells . FEBS Letters . 65 . 2 . 246–50 . June 1976 . 6335 . 10.1016/0014-5793(76)80490-5 . 34210226 .
  17. Gill AC, Ritchie MA, Hunt LG, Steane SE, Davies KG, Bocking SP, Rhie AG, Bennett AD, Hope J . Post-translational hydroxylation at the N-terminus of the prion protein reveals presence of PPII structure in vivo . The EMBO Journal . 19 . 20 . 5324–31 . October 2000 . 11032800 . 314005 . 10.1093/emboj/19.20.5324 .
  18. Qi HH, Ongusaha PP, Myllyharju J, Cheng D, Pakkanen O, Shi Y, Lee SW, Peng J, Shi Y . Prolyl 4-hydroxylation regulates Argonaute 2 stability . Nature . 455 . 7211 . 421–4 . September 2008 . 18690212 . 2661850 . 10.1038/nature07186 . 2008Natur.455..421Q .
  19. Daly NL, Craik DJ . Structural studies of conotoxins . IUBMB Life . 61 . 2 . 144–50 . February 2009 . 19165896 . 10.1002/iub.158 . 8678009 . free .
  20. Bacon NC, Wappner P, O'Rourke JF, Bartlett SM, Shilo B, Pugh CW, Ratcliffe PJ . Regulation of the Drosophila bHLH-PAS protein Sima by hypoxia: functional evidence for homology with mammalian HIF-1 alpha . Biochemical and Biophysical Research Communications . 249 . 3 . 811–6 . August 1998 . 9731218 . 10.1006/bbrc.1998.9234 .
  21. Smith TG, Robbins PA, Ratcliffe PJ . The human side of hypoxia-inducible factor . British Journal of Haematology . 141 . 3 . 325–34 . May 2008 . 18410568 . 2408651 . 10.1111/j.1365-2141.2008.07029.x .
  22. Bruick RK, McKnight SL . A conserved family of prolyl-4-hydroxylases that modify HIF . Science . 294 . 5545 . 1337–40 . November 2001 . 11598268 . 10.1126/science.1066373 . 2001Sci...294.1337B . 9695199 .
  23. Karuppagounder SS, Ratan RR . Hypoxia-inducible factor prolyl hydroxylase inhibition: robust new target or another big bust for stroke therapeutics? . Journal of Cerebral Blood Flow and Metabolism . 32 . 7 . 1347–61 . July 2012 . 22415525 . 10.1038/jcbfm.2012.28 . 3390817 .
  24. Warnecke C, Griethe W, Weidemann A, Jürgensen JS, Willam C, Bachmann S, Ivashchenko Y, Wagner I, Frei U, Wiesener M, Eckardt KU . Activation of the hypoxia-inducible factor-pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors . FASEB Journal . 17 . 9 . 1186–8 . June 2003 . 12709400 . 10.1096/fj.02-1062fje . free . 45194703 .
  25. Selvaraju V, Parinandi NL, Adluri RS, Goldman JW, Hussain N, Sanchez JA, Maulik N . Molecular mechanisms of action and therapeutic uses of pharmacological inhibitors of HIF-prolyl 4-hydroxylases for treatment of ischemic diseases . Antioxidants & Redox Signaling . 20 . 16 . 2631–65 . June 2014 . 23992027 . 10.1089/ars.2013.5186 . 4026215 .
  26. Muchnik E, Kaplan J . HIF prolyl hydroxylase inhibitors for anemia . Expert Opinion on Investigational Drugs . 20 . 5 . 645–56 . May 2011 . 21406036 . 10.1517/13543784.2011.566861 . 21973130 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Procollagen-proline dioxygenase".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.